Sigue la actividad de operaciones con información privilegiada más reciente de Ekso Bionics Holdings. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Ekso Bionics Holdings.
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
Los expertos no han informado de compras ni ventas en los últimos 30 días.
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Mar 14, 2024 | DIRECTOR | 13.73K | $1.13 | $15.48K | BUY | 10.23% | 147.99K | Aug 10 - Nov 02 | ||
Aug 18, 2023 | PRESIDENT & COO | -37.45K | $1.00 | -$37.28K | SELL | -10.15% | 331.37K | Aug 17 | ||
Aug 18, 2023 | CHIEF FINANCIAL OFFICER | -12.78K | $1.00 | -$12.73K | SELL | -4.57% | 266.95K | Aug 17 | ||
May 26, 2023 | EXECUTIVE CHAIR | -45.66K | $1.44 | -$65.87K | SELL | -11.12% | 364.91K | May 24 | ||
May 17, 2023 | CHIEF OPERATING OFFICER | -3.44K | $1.57 | -$5.40K | SELL | -2.42% | 138.55K | May 08 | ||
Dec 07, 2022 | EXECUTIVE CHAIR | 263.30K | $1.28 | -$13.49K | SELL-OPTIONS | 37.19% | 971.34K | Dec 04 | ||
Nov 23, 2022 | CEO & CHAIRMAN | 9.81K | $1.26 | -$7.31K | SELL-OPTIONS | 1.41% | 708.04K | Nov 21 | ||
Nov 17, 2022 | SENIOR VP PRODUCT DEVELOPMENT | -782.00 | $1.28 | -$1.00K | SELL | -0.62% | 124.98K | Nov 16 | ||
Nov 17, 2022 | CHIEF FINANCIAL OFFICER | -723.00 | $1.28 | -$927.25 | SELL | -0.71% | 101.47K | Nov 16 | ||
Oct 26, 2022 | CEO & CHAIRMAN | 9.68K | $1.29 | -$7.62K | SELL-OPTIONS | 1.41% | 698.23K | Oct 21 - Oct 24 | ||
Sep 26, 2022 | CEO & CHAIRMAN | 9.56K | $1.75 | -$10.55K | SELL-OPTIONS | 1.41% | 688.55K | Sep 21 - Sep 22 | ||
Sep 02, 2022 | SENIOR VP PRODUCT DEVELOPMENT | -5.87K | $2.31 | -$13.59K | SELL | -4.46% | 125.76K | Aug 31 | ||
Aug 23, 2022 | CEO & CHAIRMAN | 10.03K | $2.20 | -$12.28K | SELL-OPTIONS | 1.50% | 679.00K | Aug 21 - Aug 22 | ||
Aug 04, 2022 | INTERIMCHIEF FINANCIAL OFFICER | -1.68K | $1.80 | -$3.02K | SELL | -1.61% | 102.19K | Aug 03 | ||
Jul 25, 2022 | CEO & CHAIRMAN | 9.94K | $1.75 | -$9.91K | SELL-OPTIONS | 1.51% | 668.97K | Jul 21 - Jul 25 | ||
Jul 20, 2022 | INTERIMCHIEF FINANCIAL OFFICER | -98.00 | $1.71 | -$167.13 | SELL | -0.09% | 103.87K | Jul 18 | ||
Jul 05, 2022 | PRESIDENT & COO | -5.00K | $1.72 | -$8.59K | SELL | -1.34% | 368.82K | Jun 30 | ||
Jun 22, 2022 | CEO & CHAIRMAN | 10.27K | $1.74 | -$9.26K | SELL-OPTIONS | 1.58% | 659.03K | Jun 21 - Jun 22 | ||
Jun 17, 2022 | CEO & CHAIRMAN | 11.35K | $1.90 | -$13.12K | GRANT | 1.78% | 648.76K | Jun 10 - Jun 15 | ||
May 26, 2022 | CEO & CHAIRMAN | -6.60K | $1.76 | -$11.60K | SELL | -1.02% | 637.41K | May 24 | ||
May 02, 2022 | CEO & CHAIRMAN | -6.86K | $2.41 | -$16.52K | SELL | -1.08% | 628.41K | Apr 28 | ||
Apr 26, 2022 | PRESIDENT & COO | -4.04K | $2.62 | -$10.58K | SELL | -5.19% | 73.81K | Apr 20 | ||
Mar 28, 2022 | CHIEF FINANCIAL OFFICER | -3.46K | $2.82 | -$9.76K | SELL | -8.97% | 35.13K | Mar 22 | ||
Mar 28, 2022 | VP PRODUCT DEVELOPMENT | -3.27K | $2.82 | -$9.21K | SELL | -3.85% | 81.64K | Mar 22 | ||
Mar 25, 2022 | CEO & CHAIRMAN | -6.39K | $2.94 | -$18.78K | SELL | -1.02% | 619.67K | Mar 24 | ||
Mar 17, 2022 | CEO & CHAIRMAN | -5.96K | $2.60 | -$15.51K | SELL | -0.97% | 610.46K | Mar 15 |
Explora operaciones con información privilegiada sobre todos los valores.